Predilife S.A. (FRA:0GA)

Germany · Delayed Price · Currency is EUR

0.7320

0.00 (0.00%)

Last updated: Oct 23, 2026, 8:01 AM CEST

Market Cap	3.99M -65.8%
Revenue (ttm)	835.81K +69.5%
Net Income	-3.93M
EPS	-1.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	459
Open	0.7320
Previous Close	0.7320
Day's Range	0.7320 - 0.7320
52-Week Range	0.7320 - 3.4800
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 29, 2026

About Predilife

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. It provides breast cancer predictive assessment; and multi-pathology predictive assessment. The company also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2004

Employees 21

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 0GA

Financial Performance

In 2025, Predilife's revenue was 835,809, an increase of 69.47% compared to the previous year's 493,202. Losses were -3.93 million, -7.74% less than in 2024.

Financial Statements